BI
BML Investment Partners, L.P. disclosed a 6.7% stake in LENZ
BML Investment Partners, L.P. reported owning 6.7% of LENZ Therapeutics, Inc. (LENZ) (2,110,727 shares) in a Schedule 13G filed Nov 4, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 4, 2026
- Source
- Schedule 13G